Number (percentage) of patients in groups differing in the percentage of GOLPH3 positive prostate cancer cells (“A” score in IRS scale) in the material from the prostate or metastatic lymph node, risk factors, and results of chi-square tests of independence. This evidence concerns the gene GOLPH3 and prostate cancer.